These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 8137105

  • 21. D2 dopamine receptor up-regulation, treatment response, neurological soft signs, and extrapyramidal side effects in schizophrenia: a follow-up study with 123I-iodobenzamide single photon emission computed tomography in the drug-naive state and after neuroleptic treatment.
    Schröder J, Silvestri S, Bubeck B, Karr M, Demisch S, Scherrer S, Geider FJ, Sauer H.
    Biol Psychiatry; 1998 May 01; 43(9):660-5. PubMed ID: 9582999
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [99mTc]TRODAT-1/[123I]IBZM SPECT studies of the dopaminergic system in Tourette syndrome.
    Hwang WJ, Yao WJ, Fu YK, Yang AS.
    Psychiatry Res; 2008 Feb 28; 162(2):159-66. PubMed ID: 18248965
    [Abstract] [Full Text] [Related]

  • 25. Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.
    Schlegel S, Schlösser R, Hiemke C, Nickel O, Bockisch A, Hahn K.
    Psychopharmacology (Berl); 1996 Apr 28; 124(3):285-7. PubMed ID: 8740053
    [Abstract] [Full Text] [Related]

  • 26. Effect of haloperidol dose on iodine-123-IBZM brain SPECT imaging in schizophrenic patients.
    Vallabhajosula S, Hirschowitz J, Machac J.
    J Nucl Med; 1997 Feb 28; 38(2):203-7. PubMed ID: 9025736
    [Abstract] [Full Text] [Related]

  • 27. Loss of dopamine-D2 receptor binding sites in Parkinsonian plus syndromes.
    Hierholzer J, Cordes M, Venz S, Schelosky L, Harisch C, Richter W, Keske U, Hosten N, Mäurer J, Poewe W, Felix R.
    J Nucl Med; 1998 Jun 28; 39(6):954-60. PubMed ID: 9627325
    [Abstract] [Full Text] [Related]

  • 28. [123I]IBZM SPECT in patients treated with typical and atypical neuroleptics: relationship to drug plasma levels and extrapyramidal side effects.
    Schlösser R, Schlegel S, Hiemke C, Nickel O, Bockisch A, Rao ML, Hahn K.
    Psychiatry Res; 1997 Sep 29; 75(2):103-14. PubMed ID: 9351492
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
    Hierholzer J, Cordes M, Schelosky L, Richter W, Keske U, Venz S, Semmler W, Poewe W, Felix R.
    J Nucl Med; 1994 Dec 29; 35(12):1921-7. PubMed ID: 7989970
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Marked reduction of striatal dopamine D2 receptors as detected by 123IBZM-SPECT in a Wilson's disease patient with generalized dystonia.
    Schwarz J, Tatsch K, Vogl T, Kirsch CM, Trenkwalder C, Arnold G, Gasser T, Oertel WH.
    Mov Disord; 1992 Dec 29; 7(1):58-61. PubMed ID: 1532631
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls.
    Yang YK, Chiu NT, Chen CC, Chen M, Yeh TL, Lee IH.
    Psychiatry Res; 2003 Jul 30; 123(3):191-7. PubMed ID: 12928107
    [Abstract] [Full Text] [Related]

  • 36. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
    Knable MB, Jones DW, Coppola R, Hyde TM, Lee KS, Gorey J, Weinberger DR.
    J Nucl Med; 1995 Jul 30; 36(7):1216-25. PubMed ID: 7790947
    [Abstract] [Full Text] [Related]

  • 37. Striatal D2 receptor binding in sleep bruxism: a controlled study with iodine-123-iodobenzamide and single-photon-emission computed tomography.
    Lobbezoo F, Soucy JP, Montplaisir JY, Lavigne GJ.
    J Dent Res; 1996 Oct 30; 75(10):1804-10. PubMed ID: 8955676
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Dopaminergic neurotransmission in patients with schizophrenia in relation to positive and negative symptoms.
    Pogarell O, Koch W, Karch S, Dehning S, Müller N, Tatsch K, Poepperl G, Möller HJ.
    Pharmacopsychiatry; 2012 May 30; 45 Suppl 1():S36-41. PubMed ID: 22565233
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.